Skip to main content

Table 2 Clinical information of HIV-1 seropositive donors on combination ART (longitudinal study)

From: Transcriptome analysis of monocyte-HIV interactions

   CD4T count (cells/mm3) VL (log copies/ml)
Patient ID Experiment BL M3 M6 M9 BL M3 M6 M9
HA 01 MAS 239 373 407 502 4.61 2.37 < 1.70 < 1.70
HA 02 MAS 153 222 353 263 5.36 1.75 1.85 < 1.70
HA 03 MAS 193 441 446 437 5.36 2.84 1.72 2.05
HA 04 MAS 273 608 577 761 4.58 < 1.70 < 1.70 < 1.70
HA 05 MAS 548 592 956 778 4.88 2.12 < 1.70 < 1.70
HA 06 MAS 239 317 348 591 5.01 < 2.60 < 1.70 < 1.70
HA 07 MAS 165 209 282 222 5.13 < 2.60 < 2.60 < 1.70
HA 08 MAS 146 241 264 315 4.48 < 1.70 < 1.70 < 1.70
HA 09 MAS 205 ND 400 318 5.45 ND < 1.70 < 1.70
HA 10 MAS 269 327 451 372 5.26 < 1.70 < 1.70 < 1.70
HA 11 MAS 324 707 561 590 5.68 3.26 < 2.60 < 2.60
HA 12 MAS 202 245 254 242 5.16 < 1.70 < 1.70 < 1.70
HA 13 MAS 261 ND 425 432 5.77 ND < 1.70 < 1.70
HA 14 MAS 318 257 270 338 5.14 < 1.70 < 1.70 < 1.70
HA 15 MAS 258 524 462 300 4.57 2.35 < 1.70 < 1.70
HA 16 MAS 232 356 358 318 5.57 < 2.60 3.85 < 1.70
  1. MAS: custom Macrophage Activation State array platform; CL: commercial CodeLink HWG bioarray platform; CD4T: CD4+ T lymphocyte; VL: viral load; BL: baseline; M3/6/9: sample taken resp. 3, 6 and 9 months after therapy initiation; ND: not done.
\